loading

Xenetic Biosciences Inc Borsa (XBIO) Ultime notizie

pulisher
Jul 24, 2025

When is the best time to buy Xenetic Biosciences Inc. stockHigh-yield capital appreciation - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

Xenetic Biosciences, Inc. Expands Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform - Greenville Online

Jul 24, 2025
pulisher
Jul 23, 2025

Xenetic Biosciences Inc. Stock Analysis and ForecastHigh-yield market plays - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Xenetic expands DNase-I collaboration with Scripps Research By Investing.com - Investing.com India

Jul 23, 2025
pulisher
Jul 23, 2025

Revolutionary Cancer Treatment: Xenetic and Scripps Advance DNase-CAR-T Therapy for Lymphoma and Leukemia - Stock Titan

Jul 23, 2025
pulisher
Jul 23, 2025

What drives Xenetic Biosciences Inc. stock priceExceptional portfolio growth - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Xenetic Biosciences Inc. stockRobust investment performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Xenetic Biosciences Inc. a good long term investmentConsistently exceptional gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 16, 2025

Why Xenetic Biosciences Inc. stock attracts strong analyst attentionLow Risk High Reward Picks - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Xenetic Biosciences Inc. stock price move sharplyFree Exclusive Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Xenetic Biosciences Inc. stock performs during market volatilityOptimized Return Investment Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Xenetic Biosciences (NASDAQ:XBIO) Shares Down 8% – What’s Next? - Defense World

Jul 15, 2025
pulisher
Jul 12, 2025

Head to Head Comparison: Xenetic Biosciences (NASDAQ:XBIO) versus Vaxart (NASDAQ:VXRT) - Defense World

Jul 12, 2025
pulisher
Jul 09, 2025

Xenetic Biosciences, Inc. Announces Update from Collaboration Partner of First Patient Dosed in Exploratory Clinical Study of DNase I in Combination with FOLFIRINOX for the First Line Treatment of Unresectable, Locally Advanced or Metastatic Pancreatic C - The Holland Sentinel

Jul 09, 2025
pulisher
Jul 09, 2025

New to The Street Announces Media Coverage of BitMine Immersion Technologies Inc., Including NewsOut Video PR Integration - Great Falls Tribune

Jul 09, 2025
pulisher
Jul 08, 2025

North Shore Uranium Engages Investing News Network - Great Falls Tribune

Jul 08, 2025
pulisher
Jul 08, 2025

LQR House Announces Strategic Marketing Cooperation with Montauk Distilling Co. for Cinnamon Flavored Rum - Great Falls Tribune

Jul 08, 2025
pulisher
Jul 08, 2025

Monogram Technologies Announces the Mandatory Conversion of 8.00% Series D Convertible Cumulative Preferred Stock - Great Falls Tribune

Jul 08, 2025
$23.29
price down icon 1.74%
$36.50
price up icon 0.00%
$103.56
price down icon 0.03%
$27.38
price down icon 0.69%
$113.86
price down icon 0.68%
biotechnology ONC
$288.37
price down icon 2.39%
Capitalizzazione:     |  Volume (24 ore):